Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 91 AL 105

Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes

Silva T, Reis J, Teixeira J, Borges F.

Ageing Res Rev. 2014 May;15:116-45. doi: 10.1016/j.arr.2014.03.008. Epub 2014 Apr 13.

Tau-based therapeutic approaches for Alzheimer's disease - a mini-review

Boutajangout A, Wisniewski T.

Gerontology. 2014;60(5):381-5. doi: 10.1159/000358875. Epub 2014 Apr 8.

[Tolerability and efficacy of the long-term administration of memantine hydrochloride (Memary®) in patients with moderate to severe Alzheimer's disease]

Kitamura S, Nakamura Y, Homma A, Kimura N, Asami Y.

Nihon Ronen Igakkai Zasshi. 2014;51(1):74-84. doi: 10.3143/geriatrics.51.74.

Drug treatments for Alzheimer's disease

Jackson GA.

Nurs Times. 2014 Feb 26-Mar 4;110(9):24-6.

[Progress of experimental research on treating Alzheimer's disease by acupuncture]

Liu YJ, Fu Y.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Mar;34(3):359-61.

Clinical trials of intravenous immunoglobulin for Alzheimer's disease

Relkin N.

J Clin Immunol. 2014 Jul;34 Suppl 1:S74-9. doi: 10.1007/s10875-014-0041-4. Epub 2014 Apr 24.

[Alzheimer's disease and caregivers experience in home care]

Daga E, Corvo E, Marucci AR, Sansoni J.

Prof Inferm. 2014 Jan-Mar;67(1):5-14. doi: 10.7429/pi.2014.671005.

Cardiovascular effects of drugs used to treat Alzheimer's disease

Howes LG.

Drug Saf. 2014 Jun;37(6):391-5. doi: 10.1007/s40264-014-0161-z.

Immunomodulation and AD--down but not out

Knight EM, Gandy S.

J Clin Immunol. 2014 Jul;34 Suppl 1:S70-3. doi: 10.1007/s10875-014-0039-y. Epub 2014 Apr 30.

Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease

Prvulovic D, Schneider B.

Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1039-50. doi: 10.1517/17425255.2014.915028. Epub 2014 Apr 30.

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations

Xu J, Kong X, Qiu L, Geng X, Hu Y, Wang Y.

Expert Opin Ther Pat. 2014 Jul;24(7):791-800. doi: 10.1517/13543776.2014.915943. Epub 2014 May 5.

Rethinking dementia

Dennison R.

Br J Community Nurs. 2014 Jan;19(1):5. doi: 10.12968/bjcn.2014.19.1.5.

Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status

Ramirez MJ, Lai MK, Tordera RM, Francis PT.

Drugs. 2014 May;74(7):729-36. doi: 10.1007/s40265-014-0217-5.

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease

Bayer TA, Wirths O.

Acta Neuropathol. 2014;127(6):787-801. doi: 10.1007/s00401-014-1287-x. Epub 2014 May 7.

[Acetylcholinesterase inhibitors for treatment of Alzheimer's disease]

Shinagawa S, Shigeta M.

Brain Nerve. 2014 May;66(5):507-16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias